Cohance Lifesciences Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹422.26 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 31.80 per cent from ₹619.12 crore. This corresponds to a year-on-year *(YoY) decline of 23.13 per cent.
Operating Profit
Operating Profit stands at ₹1.16 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 98.59 per cent from ₹82.17 crore. This corresponds to a year-on-year *(YoY) decline of 98.88 per cent.
PBDT
PBDT stands at ₹6.67 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 90.62 per cent from ₹71.14 crore. This corresponds to a year-on-year *(YoY) decline of 93.82 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-42.87 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 315.32 per cent from ₹19.91 crore. This corresponds to a year-on-year *(YoY) decline of 168.31 per cent.
Net Profit
Net Profit stands at ₹-45.19 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 643.80 per cent from ₹8.31 crore. This represents a 197.39 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Cohance Lifesciences Ltd Earnings
- YOY
- QOQ
Cohance Lifesciences Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Cohance Lifesciences Ltd Research Reports
Cohance Lifesciences Ltd Financial Reports
Cohance Lifesciences Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Cohance Life | 0.04% | -1.65% | 1.22% | 5.00% | 52.99% | -54.28% |
| Shilpa Medicare | 1.76% | 0.50% | 18.95% | 71.94% | 183.42% | 130.13% |
| ERIS Lifescience | -0.33% | 1.48% | -4.98% | -3.12% | -2.04% | -23.02% |
| OneSource Speci. | 1.52% | 0.69% | 0.61% | -6.93% | 7.69% | -14.10% |
| Astrazeneca Phar | -0.47% | -1.58% | -15.36% | -17.67% | -22.32% | -23.90% |
| Alivus Life | -0.67% | -2.93% | 0.24% | 33.68% | 46.63% | 44.94% |
| Jubilant Pharmo | 5.02% | 10.12% | 3.78% | 3.50% | 22.85% | -12.36% |
Company Info
Company Information
Chairman & Exec. Director : Vivek Sharma
Non-Exec & Non-Independent Dir : Vinod Padikkal
Independent Non Exe. Director : K G Ananthakrishnan
Independent Non Exe. Director : Matangi Gowrishankar
Independent Non Exe. Director : Vinod Rao
Independent Non Exe. Director : U B Pravin Rao
Independent Non Exe. Director : Jaishankar Krishnan
Non Executive Director : Pankaj Patwari
Non Executive Director : Shweta Jalan
CS / Compliance Officer / Legal Head : KUNDAN KUMAR JHA
Whole Time Director & Chief Financial Officer : Himanshu Agarwal